Interleukin-mediated therapies in liver diseases and comorbidity effects.

Comorbidity Cytokines Interleukins Liver diseases Therapy

Journal

World journal of hepatology
ISSN: 1948-5182
Titre abrégé: World J Hepatol
Pays: United States
ID NLM: 101532469

Informations de publication

Date de publication:
27 Jul 2024
Historique:
received: 28 02 2024
revised: 13 05 2024
accepted: 17 05 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: ppublish

Résumé

Cytokines like interleukins (ILs) play important roles in inflammation and innate immune. Yang and Zhang carried out an interesting study related to ILs and hepatic diseases. They described the role of ILs in the pathogenesis and resolution of hepatic disorders. The authors summarized alcohol-related liver disease and virus-induced hepatitis, as far as clinical studies

Identifiants

pubmed: 39086534
doi: 10.4254/wjh.v16.i7.980
pmc: PMC11287617
doi:

Types de publication

Editorial

Langues

eng

Pagination

980-989

Informations de copyright

©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: Any conflict of interest to disclose.

Auteurs

Nouhoum Bouare (N)

Department of Quality, Hygien, Biosafety/Biosecurity and Pharmacovigilence, National Institute of Public Health, Bamako 1771, Mali. nouhoumsamakoro@yahoo.fr.

Jean Delwaide (J)

Department of Gastroenterology and Hepatology, CHULiege, Liege 4000, Belgium.

Classifications MeSH